Arkema announces a project for the sale to INEOS of its 50% stake in Oxochimie, their oxo alcohols manufacturing joint venture, and the associated business.
Arkema produces oxo alcohols on the Lavéra site (France) in a 50/50 manufacturing joint venture with INEOS. These products are used in part for the production of the Group’s acrylic esters in Europe. They are also sold on the free market for annual sales of some 40 million euros.
As part of the program to divest €700 million sales, the Group announces the project to divest to INEOS its stake in Oxochimie, as well as the associated business. Furthermore, INEOS will continue to supply the Group’s acrylic esters units.
The project, due to be finalized early 2017, is subject to an information and consultation process of social work councils and approval of the relevant antitrust authorities.
Source: Arkema
France has launched an offshore green hydrogen production platform at the country’s Port of Saint-Nazaire this week, along with its first offshore wind farm. The hydrogen plant, which its operators say is the world’s first facility of its type, coincides with the launch of another “first of its kind” facility in Sweden dedicated to storing hydrogen in an underground lined rock cavern (LRC).
The project sets up the Hydrogen Valley in Rome, the first industrial-scale technological hub for the development of the national supply chain for the production, transport, storage and use of hydrogen for the decarbonization of industrial processes and for sustainable mobility.
At first glance, hydrogen seems to be the perfect solution to our energy needs. It doesn’t produce any carbon dioxide when used. It can store energy for long periods of time. It doesn’t leave behind hazardous waste materials, like nuclear does. And it doesn’t require large swathes of land to be flooded, like hydroelectricity. Seems too good to be true. So…what’s the catch?
